Novel immunotherapy approach shows promise in blood cancers

Cancer researchers show that injecting substances that mimic tumor-cell DNA into the bloodstream can stimulate the STING pathway to provoke a life-extending immune response in mice with acute myeloid leukemia. This is the first demonstration that this approach could be effective in widely disseminated ‘liquid’ cancers, such as leukemia.